Single-atom nanozyme-based wireless microfluidic sensing platform for noninvasive hyperuricemia diagnosis
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.119098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Jiaying Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, Translational Research of Diabetes Key Laboratory of Chongqing,…. Hauptthemen laut MEDLINE: Hyperuricemia, Uric Acid, Biosensing Techniques, Lab-On-A-Chip Devices. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Chongqing Municipal Education Commission, National Science Fund for Distinguished Young Scholars, National Science and Technology Major Project.
Abstract (Originalsprache)
Hyperuricemia is characterized by abnormally elevated serum uric acid (UA) levels. Persistent hyperuricemia not only triggers gout but also causes damage to the kidneys and cardiovascular system. Therefore, utilizing non-invasive diagnostic methods for early and continuous monitoring is crucial for preventing disease progression. Herein, we reported a portable wireless electrochemical sensing platform constructed from SA-Pt/rGO/MOF catalysts prepared via photochemical deposition of platinum single atoms (Pt SAs) on reduced graphene oxide/metal-organic framework (rGO/MOF) composites. The designed single-atom catalysts (SACs) exhibited exceptional electrocatalytic activity toward UA oxidation, and the fabricated sensing platform demonstrated a broad linear detection range (1-1000 μM) and relatively low detection limit (1.12 μM), with excellent selectivity and reproducibility. To enhance direct biofluid analysis, we designed a hydrophilic surface-modified microfluidic device for enhanced collection efficiency. Building upon this device, the integrated wireless microfluidic electrochemical platform enabled quantitative UA analysis and correlation studies in serum and saliva from 10 hyperuricemia patients and 10 healthy volunteers, demonstrating promising clinical utility. This work not only extended SACs applications to ultrasensitive biomarker detection but also provided a feasible strategy for developing next-generation non-invasive point-of-care testing (POCT) devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Metabolic and Chronic Disease Science Innovation Center, Translational Research of Diabetes Key Laboratory of Chongqing, The Second Affiliated Hospital of Army Medical University, Chongqing,…
- Department of Clinical Laboratory, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Förderung
- Chongqing Municipal Education Commission
- National Science Fund for Distinguished Young Scholars
- National Science and Technology Major Project
- National Natural Science Foundation of China
Zitieren
APA
Zhao, J., Zheng, J., Wei, K., He, Q., Zhang, C., Tian, C., Wang, Q., Liu, X., Yang, G., Qu, H., Zheng, H., & Zheng, Y. (2026). Single-atom nanozyme-based wireless microfluidic sensing platform for noninvasive hyperuricemia diagnosis. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119098
Vancouver
Zhao J, Zheng J, Wei K, He Q, Zhang C, Tian C, et al. Single-atom nanozyme-based wireless microfluidic sensing platform for noninvasive hyperuricemia diagnosis. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.119098
BibTeX
@article{Zhao2026,
author = {Zhao, Jiaying and Zheng, Jia and Wei, Kezheng and He, Qingshan and Zhang, Chunlin and Tian, Chenfu and Wang, Qixian and Liu, Xiufei and Yang, Guojun and Qu, Hua and Zheng, Hongting and Zheng, Yi},
title = {Single-atom nanozyme-based wireless microfluidic sensing platform for noninvasive hyperuricemia diagnosis},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.119098}
}
EUVIMED